<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K\A
(Mark One)
/X/ Annual Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 (Fee Required)
For the fiscal year ended December 31, 1994, or
/ / Transition Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 (No Fee Required) - For the transition period from
______to______
Commission File Number 0-12787
MEDICAL IMAGING CENTERS OF AMERICA, INC.
------------------------------------------------------
(Exact name of Registrant as specified in its charter)
California 95-3643045
------------------------ ---------------------------
(State of Incorporation) (I.R.S. Employer ID number)
9444 Farnham Street, Suite 100, San Diego, California 92123
----------------------------------------------------- ---------
(Address of principal executive offices) (Zip Code)
(619) 560-0110
----------------------------------------------------
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, no par value
Indicate by checkmark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No
--- ---
Indicate by checkmark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of Registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. / /
The approximate aggregate market value of the voting stock held by
nonaffiliates of the Registrant as of March 21, 1995 (based on the closing price
as reported on the OTC Bulletin Board on that date): $10,995,723
As of March 21, 1995 the Registrant had outstanding 12,136,560 shares
of Common Stock, no par value.
DOCUMENTS INCORPORATED BY REFERENCE
-----------------------------------
1
<PAGE> 2
MEDICAL IMAGING CENTERS OF AMERICA, INC.
FOR FISCAL YEAR ENDED DECEMBER 31, 1994
FORM 10-K\A ANNUAL REPORT
INDEX
<TABLE>
<CAPTION>
PART I Page
------ ----
<S> <C>
Item 1. Business 3
Item 2. Properties 9
Item 3. Legal Proceedings 9
Item 4. Submission of Matters to a Vote of Shareholders 9
PART II
-------
Item 5. Market for Registrant's Common Equity and Related Shareholder Matters 10
Item 6. Selected Financial Data 11
Item 7. Management's Discussion and Analysis of Financial Condition 11
and Results of Operations
Item 8. Financial Statements and Supplementary Data 15
Item 9. Changes in and Disagreements with Accountants on Accounting 15
and Financial Disclosure
PART III
--------
Item 10. Directors and Executive Officers of the Registrant 16
Item 11. Executive Compensation 18
Item 12. Security Ownership of Certain Beneficial Owners and Management 21
Item 13. Certain Relationships and Related Transactions 23
PART IV
-------
Item 14. Exhibits, Financial Statements and Reports on Form 8-K 23
</TABLE>
2
<PAGE> 3
PART I
Item 1. Business
Medical Imaging Centers of America, Inc. ("MICA" or the "Company") is a
California corporation organized in July 1981 which provides outpatient services
and medical equipment rentals to physicians, managed care providers and
hospitals. These services include magnetic resonance imaging ("MRI"), computed
tomography ("CT"), nuclear medicine and ultrasound. The Company's operations
include diagnostic medical centers ("DMC's"), diagnostic equipment rentals,
fee-for-service agreements (fixed and mobile), and management, marketing and
related support services.
MICA's strategy is to expand the range and extent of its advanced
imaging services which it provides to its customers and to capitalize on
emerging trends in the industry.
MEDICAL IMAGING INDUSTRY
Medical diagnostic imaging systems facilitate the diagnosis of disease
and disorders at an early stage, often minimizing the amount and cost of care
needed to stabilize or cure the patient and frequently obviating the need for
invasive diagnostic procedures, such as exploratory surgery. Diagnostic imaging
systems are based on the ability of energy waves to penetrate human tissue and
generate images of the body which can be displayed either on film or on a video
monitor. Imaging systems have evolved from conventional X-ray to the advanced
technologies of MRI, CT, nuclear medicine and ultrasound. The use of these
technologies has grown significantly in the United States during the last
several years due to increasing acceptance by physicians of the value of
advanced imaging technologies in the early diagnosis of disease, the expanding
applications of MRI and ultrasound (partially because they do not involve X-ray
radiation) and the growing patient base attributable to an aging population.
Due to budget restrictions, hospitals are increasingly utilizing third
parties, such as MICA, to provide these technologies and related services. To
remain viable in a highly competitive industry, hospitals seek to offer advanced
diagnostic imaging equipment and services to retain and expand their referring
physician base.
RANGE OF SERVICES
The needs of a particular hospital or physician group ("Customer")
determine the extent of the following services, which MICA can deliver either on
a fee-for-service basis or through a full service DMC.
EQUIPMENT AND RELATED SERVICES. Drawing upon its operating experience
and relationships with leading equipment manufacturers, MICA consults with its
Customer to identify the equipment best suited to meet the Customer's needs on a
cost-effective basis. The appropriate equipment is acquired through purchase or
lease by MICA. In addition, MICA assists the Customer in complying with
licensing and other regulatory requirements related to the siting of the
equipment. In conjunction with the installation of the equipment, MICA typically
enters into maintenance agreements with equipment manufacturers or other third
parties to service the newly installed equipment.
TECHNICAL AND SUPPORT STAFFING. MICA provides training and educational
programs for its own technologists as well as the Customer's technologists. At a
DMC, support personnel are also provided by MICA.
MARKETING. MICA provides its Customers with marketing services,
including the design of a marketing program to educate the referral base as to
the advanced imaging services available at the facility. MICA provides expanded
marketing services to patient referral sources, including HMO's and other health
plans.
MANAGEMENT. At a DMC, MICA assumes full managerial responsibility and
control over facility operations.
3
<PAGE> 4
DELIVERY OF SERVICES
MICA's medical services revenues are earned by the Company for the
provision of diagnostic imaging services. Such services are provided to
hospitals, primarily under fee-for-service arrangements, and to patients,
primarily under DMC arrangements. In 1994, the Company earned 49% of its medical
services revenues from fee-for-service arrangements (15% serviced by mobile
units and 34% serviced by fixed sites) and 51% from its DMCs.
FEE-FOR-SERVICE. Under a typical fee-for-service arrangement, MICA
furnishes the Customer with appropriate equipment and bills the Customer for the
number of patient procedures performed each month. Under certain fee-for-service
arrangements, the Customer agrees to a monthly guaranteed minimum payment. The
Company contracts to provide services for a term of one month to three years
(with the average being one year). Based upon the Customer's service
requirements, MICA installs equipment or schedules service by one of its mobile
units. A mobile unit is totally self-contained and usually provides services to
a number of Customers. During 1994, the Company provided diagnostic imaging
services to approximately 130 Customers in 20 states under fee-for-service
contracts. Of the 130 customers serviced in 1994, 73 customers received service
on site and the remaining customers received service by one of the Company's
mobile units.
DIAGNOSTIC MEDICAL CENTERS. DMC's provide advanced diagnostic imaging
services in an outpatient environment. In addition to the equipment, MICA also
provides the management of all technical and support staff; marketing services;
patient scheduling, billing and collection services; and management information
systems. Staffing for a DMC typically requires six to twenty non-physician
personnel, including technologists, supervisors, billing and collection
personnel, scheduling coordinators, and an administrative/marketing manager.
The typical arrangement for a DMC is a limited partnership (with MICA
as the managing general partner) which provides for a sharing of earnings
between MICA and its partner. In addition, MICA receives management fees of
8-10% of collected revenues. The Company carefully selects its DMC partners and
generally requires longer term exclusive contracts than it obtains in its
fee-for-service arrangements. MICA funds net operating losses of the DMC's.
4
<PAGE> 5
Set forth below is a table of MICA's DMC's with a listing of respective
opening dates and services provided at each location. In 1992, the Company also
established a freestanding radiation therapy center as a joint venture with a
Florida HCA hospital.
<TABLE>
<CAPTION>
Services by Technology
------------------------------------------------------------
Opening Nuclear
DMC Location Date MRI CT Ultrasound Medicine Other(1)
----------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
Long Beach, CA 12/84 x x x x x
Bakersfield, CA 5/85 x x x -- x
Kansas City, MO 5/85 x -- -- -- --
Portland, OR 12/85 x x x -- x
Huntington Beach, CA 12/85 x x x x x
Orlando, FL 6/87 x x x x x
Newport Beach, CA 9/87 x x x x x
Phoenix, AZ (2) 8/91 x x -- -- --
Westlake Village, CA 10/91 x -- -- -- --
Gainesville, FL 3/90 x x -- -- --
Renton, WA 3/90 x -- -- -- --
Bradenton, FL 5/90 x x -- -- --
St. Louis, MO 10/90 x -- -- -- --
Ft. Myers, FL 3/92 x -- -- -- --
Milford, DE 3/92 x -- -- -- --
Laguna Niguel, CA 6/92 x -- -- -- --
Chalmette, LA 6/92 x -- -- -- --
Santa Maria, CA 8/92 x -- -- -- --
Downey, CA 7/94 x -- -- -- --
----------------------------------------------------------------------------------------------------
</TABLE>
(1) Other services consist principally of mammography and X-ray.
(2) MICA provides only management services to this DMC.
5
<PAGE> 6
TECHNOLOGY SOURCES
MICA obtains its advanced diagnostic equipment from various
manufacturers including The General Electric Company and Hitachi Medical
Systems, Inc. Costs to acquire various new equipment are as follows:
<TABLE>
<CAPTION>
Equipment Price Range
-----------------------------------------------------------------------------------
<S> <C>
MRI $ 700,000 to $1,800,000
CT $ 150,000 to $ 650,000
Nuclear Medicine $ 125,000 to $ 350,000
Ultrasound $ 80,000 to $ 250,000
</TABLE>
Installation and maintenance costs on the equipment can be substantial,
particularly with respect to MRI units. Installation costs can range from
$75,000 to $200,000 for an MRI unit depending on the particular installation.
Maintenance costs for an MRI unit can be as high as $150,000 per year. MICA
typically enters into agreements with equipment manufacturers or other third
party service organizations for equipment maintenance.
Equipment is financed by MICA (with terms ranging from five to seven
years) with lenders and lessors, with the equipment pledged as security for the
debt.
OBSOLESCENCE
MICA attempts to select equipment that will remain commercially viable
for the duration of its financing term. Technology, however, as it relates to
MRI and CT has advanced rapidly over the past several years and all of the
Company's equipment is subject to the risk of obsolescence and price
deterioration. The Company routinely reviews its equipment portfolio to
determine that its carrying value is the lower of cost or net realizable value.
RISK
FEE-FOR-SERVICE. Under fee-for-service contracts that do not require
minimum payments, MICA assumes the risk that revenues generated through
utilization of its equipment will be sufficient to discharge MICA's financial
obligations to lenders and lessors. The Company attempts to finance its
acquisition of equipment and match the amortization period of such financial
obligation to the term of the Customer's contract. However, the amortization
period for specific equipment may extend beyond the term of the related
contract, requiring MICA to fund any resulting negative cash flow in the event
that it cannot redeploy the equipment.
DMC'S. MICA typically bills the patient for both the charges of the
radiologist and the charges for the technical services of the DMC. By
undertaking the responsibility for patient billing and collection activities,
MICA assumes the credit risk presented by the patient base, as well as the risk
of payment delays attendant to reimbursement through governmental programs or
third party payors. The Company estimates that 58% of the DMC's payors are
private insurance carriers or self-paying patients.
GOVERNMENT REGULATION
The Omnibus Budget Reconciliation Act of 1993 ("OBRA '93"), sometimes
referred to as "Stark II", includes federal legislation on physician ownership
and self-referrals regarding Medicare/Medicaid patients. The new legislation,
which became effective January 1, 1995, prohibits physician referrals to
non-hospital health facilities in which the referring physician has a "financial
interest".
On January 1, 1995, PORA, "Physician Ownership and Referral Act of
1993", became effective in the state of California. PORA prohibits a physician
from referring patients for covered goods and services which includes diagnostic
imaging if the physician (or his or her immediate family) has a "financial
interest" in an entity that receives the referral in the state of California.
MICA has a limited number of limited partnership units owned by physician
partners
6
<PAGE> 7
who currently refer patients to its DMC's and is in the process of acquiring
such units. It is not anticipated that such acquisitions will require
significant capital. MICA is unable to predict at this time what impact this
legislation will have upon the demand for its equipment and services.
The Florida legislature enacted the Patient Self-Referral Act of 1992.
Part of this Act imposes a fee schedule on all providers of diagnostic imaging
services and radiation therapy services limiting fees to no more that 115% of
the Medicare limiting charge for non-participating physicians for such services,
including technical and professional components. The statute specifically
excludes hospitals and physician group practices from the fee schedule. The
Company's four (4) Imaging Centers in Florida, as currently operated, would be
subject to the fee schedule and would be severely impacted if the fee schedule
ever becomes effective. In July 1992, the United States District Court for the
Northern District of Florida granted a permanent injunction, finding the statute
violative of the equal protection clause of the United States Constitution and
the Florida Constitution. The state filed a notice of appeal from this judgment.
On February 15, 1994, the United States Court of Appeals for the Eleventh
Circuit reversed the decision of the lower court. The Company has filed a
petition for rehearing with the Eleventh Circuit. The Company joined with other
plaintiffs and plaintiff-intervenors in an effort to defeat the fee cap
provision. In the interim, the Company has obtained a temporary injunction from
a Florida state court to prevent the fee schedule from applying to its
operations.
MICA is also affected by a number of states which have implemented
Certificate-of-Need ("CON") programs and by existing governmental regulations
regarding expenditures for medical technology by hospitals. CON programs vary
considerably from state to state. CON agencies primarily control the
distribution and physical allocation of technological equipment among healthcare
institutions, frequently determining which institutions may acquire new
technologies. Such determinations are based on broad concepts of "need", using
various criteria and weighing the relative need demonstrated by competing CON
applicants to ensure the equitable allocation of new technology among hospitals.
To date, the CON laws and regulations and state rate commissions have not had a
material effect on MICA's business, although there is no assurance that the laws
and regulations will not change or that rate commissions will not take actions
that may adversely affect MICA's business.
MICA's operations are subject to a variety of governmental and
regulatory requirements. For example, the storage, use and disposal of
radioactive materials in nuclear medicine is subject to regulation by Federal
and State governmental authorities, including the United States Food and Drug
Administration, the Department of Health and Human Services, the Health Care
Finance Administration ("HCFA"), and the Nuclear Regulatory Commission ("NRC").
Presently, the Company, through a subsidiary, holds licenses that relate to its
nuclear medicine activities in Illinois, Indiana and Ohio. Additionally, MICA
personnel must be licensed to operate certain equipment, and the physicians
practicing at its DMC's must have a Medicare/Medicaid provider number to receive
government reimbursement. MICA believes it is in compliance with applicable laws
and regulations.
MEDICAL REIMBURSEMENT PROGRAMS
A substantial portion of the Company's revenue is attributable to
payments made by government-sponsored healthcare programs and other third party
payors. From time to time the Federal government has proposed limiting
reimbursement for imaging services. Any change in reimbursement regulations, or
the enactment of legislation, which would have the effect of placing material
limitations on the amount of reimbursement for imaging services, could adversely
affect the operations of MICA.
In November 1991, HCFA issued regulations which implemented a
resource-based relative value scale ("RBRVS") payment system effective for
services furnished by physicians or incident to physician services on or after
January 1, 1992. The RBRVS fee schedule which has been phased in over a
four-year period will be fully effective beginning January 1995. For radiology,
the change in fee schedules has resulted in substantially lower reimbursement
for services provided to Medicare-eligible patients. Because MICA's fees for
services to Medicare-eligible patients are subject to the fee schedule for
radiology procedures, this change has resulted in lower reimbursement for
services provided by MICA to Medicare-eligible patients. Further changes to the
RBRVS program will most likely be affected by future
7
<PAGE> 8
healthcare legislation. MICA is unable to predict at this time what impact these
regulations will have upon demand for its equipment and services.
The Medicare/Medicaid Anti-Fraud and Abuse Statute (the "Anti-Kickback
Statute") prohibits certain actions or practices deemed by Congress to be
fraudulent or abusive in nature. These regulations, known as the "Safe Harbor
Regulations", provide that compliance with an applicable Safe Harbor would
immunize that arrangement from criminal prosecution or exclusion from the
Medicare and Medicaid programs. To the extent that a particular MICA arrangement
complies with an applicable Safe Harbor, MICA is guaranteed immunity from
criminal prosecution or exclusion from the Medicare and Medicaid programs based
upon its participation in the arrangement. Although some of MICA's arrangements
may not comply with all criteria contained in an applicable Safe Harbor, and
therefore such arrangements would not be entitled to Safe Harbor immunity, MICA
believes that its business structure and practices should not violate the
Anti-Kickback Statute.
Healthcare reimbursement programs are not uniformly prompt in making
required payments. Extensive payment delays are not uncommon, and MICA's future
cash flows could be adversely impacted while awaiting payment. MICA has limited
ability to cause more timely reimbursement practices by governmental agencies
and programs. Additionally, there can be no assurance that subsequent laws,
subsequent changes in present laws or interpretations of laws will not adversely
affect the Company's operations.
HEALTHCARE REFORM
The United States Congress is considering national healthcare reform.
The passage of such legislation could significantly affect how MICA's equipment
is used and services are delivered and how reimbursement for such equipment and
services will be obtained. MICA is unable to predict at this time what impact
such legislation will have upon the demand for its equipment and services.
COMPETITION
The healthcare industry in general, and the market for diagnostic
imaging services in particular, are highly competitive. MICA's DMC's and its
fee-for-service operations compete for patients with hospitals, managed care
groups and other DMC's. The Company also competes with equipment manufacturers,
leasing companies, physician groups and other providers of medical imaging
services. Many of these competitors have substantially greater resources than
MICA. MICA competes on the basis of its reputation for the quality of its
services.
INSURANCE
MICA carries workers' compensation insurance, comprehensive and general
liability coverage, fire and allied perils coverage. MICA maintains professional
liability and general liability insurance for all owned facilities in the single
limit amount of $10 million. There can be no assurance that potential claims
will not exceed this amount. MICA also requires that physicians practicing at
the DMC's carry medical malpractice insurance to cover their individual
practices. The physicians are personally responsible for the costs of the
insurance.
8
<PAGE> 9
EMPLOYEES
At December 31, 1994, MICA had 312 full-time employees including 282
employees at DMC and fee-for-service locations and 30 employees at the corporate
office. Under Section 401(k) of the Internal Revenue Code the Company instituted
a tax deferred retirement plan, whereby the Company will match 50% of an
employee's deferred salary up to a maximum of 4% of gross pay, for a maximum
matching contribution of 2%. MICA has stock option plans for officers,
directors, key employees and consultants of the Company. Grants of options under
such plans are subject to approval of the Compensation/Stock Option Committee of
the Board of Directors.
Item 2. Properties
The Company's executive offices are located at 9444 Farnham Street,
Suite 100, San Diego, California 92123. The Company occupies approximately
11,900 square footage pursuant to a two year lease extension which expires March
31, 1996.
Item 3. Legal Proceedings
MICA is a party to litigation arising in the normal course of its
business. MICA does not believe that the results of such litigation, even if
determined adversely to MICA, would have a material impact on its results of
operations, liquidity or its financial position.
Item 4. Submission of Matters to a Vote of Shareholders
None.
9
<PAGE> 10
PART II
Item 5. Market for Registrant's Common Equity and
Related Shareholder Matters
MICA has not paid and does not presently intend to pay cash dividends
on its Common Stock. Future dividends on the Common Stock will depend on
business and financial conditions, earnings and other factors and are subject to
declaration by MICA's Board of Directors at its discretion. Payment of dividends
is also restricted by the terms of the Company's 1989 convertible subordinated
debentures (see Note 8 to the consolidated financial statements).
At March 21, 1995, MICA had approximately 3,000 beneficial owners of
the Common Stock. Effective June 23, 1994, MICA's Common Stock was delisted for
non-compliance with the capital requirements of the National Association of
Securities Dealers, Inc. and is no longer included for quotation on the NASDAQ
Stock Market's National Market (the "NASDAQ National Market"). The Common Stock
is traded on the OTC Bulletin Board under the symbol "MIKA".
The following table sets forth, for the periods indicated, the high and
low bid prices of the Common Stock, as reported by the NASDAQ National Market
and the OTC Bulletin Board, respectively, for the last two years. These
quotations represent prices between dealers and do not include retail markups,
markdowns, commissions or other adjustments, and may not represent actual
transactions.
<TABLE>
<CAPTION>
1994 1993
Common Stock Common Stock
------------------- -------------------
Quarter High Low High Low
------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
1st $ 7/8 $ 7/16 $2 3/4 $ 1/2
2nd 3/4 3/8 1 3/8 15/32
3rd 1 3/8 1 1/8 1/2
4th 1 11/16 1 5/8 11/16
</TABLE>
10
<PAGE> 11
Item 6. Selected Financial Data
<TABLE>
<CAPTION>
Year ended December 31,
-------------------------------------------------------------
(In thousands, except per share information) 1994 1993 1992 1991 1990(1)
-----------------------------------------------------------------------------------------------------------------------
SELECTED OPERATING DATA:
<S> <C> <C> <C> <C> <C>
Total revenues $57,306 $ 68,797 $ 84,558 $ 88,079 $ 78,264
Medical services revenues $55,440 $ 65,786 $ 74,258 $ 73,926 $ 62,572
Income (loss) before extraordinary gain $(1,810) $(29,613) $ (20,342) $ (10,449) $ 6,181
Extraordinary gain $ 1,316 $ -- $ -- $ -- $ --
Net income (loss) $ (494) $(29,613) $ (20,342) $ (10,449) $ 6,181
Net income (loss) per share
Primary
Income (loss) before extraordinary gain $ (.15) $ (2.51) $ (1.72) $ (.90) $ .63
Extraordinary gain $ .11 $ -- $ -- $ -- $ --
Net income (loss) $ (.04) $ (2.51) $ (1.72) $ (.90) $ .63
Weighted average primary shares
outstanding 12,129 11,805 11,801 11,578 9,739
</TABLE>
----------
(1) Fully diluted earnings per share were $.61.
SELECTED BALANCE SHEET DATA:
<TABLE>
<S> <C> <C> <C> <C> <C>
Cash $ 8,524 $ 8,182 $ 4,862 $ 7,328 $ 6,426
Working capital (deficit) $(1,467) $ 3,421 $ (673) $ 9,046 $ 21,696
Total assets $53,469 $ 65,697 $ 108,928 $ 125,567 $ 108,293
Convertible debentures $11,000 $ 11,000 $ 11,000 $ 11,000 $ 12,500
Long-term debt and capital lease obligations $25,406 $ 35,509 $ 45,120 $ 43,706 $ 22,535
Shareholders' equity (net capital deficiency) $(2,861) $ (2,370) $ 27,243 $ 46,715 $ 55,207
</TABLE>
Item 7. Management's Discussion and Analysis of
Financial Condition and Results of Operations
LIQUIDITY AND CAPITAL RESOURCES
Although the Company has reported net operating losses since 1991, such
losses have declined significantly during the last fiscal year. At year end, the
Company's cash and cash equivalents exceeded $8.5 million; however, the Company
had a working capital deficit of $1.5 million. The working capital deficit is
due to a $2.8 million mandatory redemption of convertible debentures due in
April of 1995 (see Note 8 to MICA's consolidated financial statements). During
1994, the Company funded its losses with cash generated from operations. Cash
flows from operations of $14.9 million and proceeds from long-term borrowings of
$1.1 million were offset by payments against long-term debt of $11.9 million and
capital expenditures of $3 million.
The Company's ability to meet its current obligations is dependent on
its ability to maintain revenues from existing contracts while reducing related
costs. In addition, a number of factors exist that could have an impact on the
Company's future revenues: (i) declining prices and an oversupply in the
diagnostic equipment market; (ii) changes in healthcare legislation which has
limited reimbursement and prohibited referrals from physician investors; (iii)
healthcare initiatives which could reduce reimbursement to the Company; and (iv)
competition in the healthcare industry.
Management believes that the actions taken in 1994 to terminate
unprofitable contracts, sell underperforming assets and renegotiate various
maintenance and lease agreements have positioned the Company to continue
operating given the current reimbursement dynamics of the diagnostic imaging
industry. The Company will continue to evaluate its operating costs and reduce
spending as appropriate; however, there can be no assurances that such actions
will be sufficient to provide adequate cash to sustain the operations of the
Company.
11
<PAGE> 12
During the years 1991 through 1993, the Company recognized significant
special charges related to its write-off of goodwill and the establishment of
reserves for uncollectible accounts and certain assets carried on the books at
greater than their net realizable value. These charges were substantially
non-cash and therefore did not have a significant impact on the Company's
liquidity (see Note 13).
GENERAL OPERATING TRENDS
Medical services revenues declined during 1994 primarily due to the
Company's termination of unprofitable fee-for-service contracts and sales of
underperforming assets. In addition, declining reimbursement continues to
adversely impact revenues earned by the Company which is the direct result of
cost containment efforts at the state and federal level as well as the efforts
by insurer and payor groups to reduce healthcare costs. MICA expects the decline
in reimbursement trends to continue in the future.
The Company's strategy is to offset the declining trends in
reimbursement by securing managed care contracts and developing strategic
alliances with hospitals and other healthcare providers to increase the
utilization of its imaging services. By positioning itself to take greater
advantage of managed care contracts, thereby increasing the utilization of its
services, management believes that it can maintain its DMC revenues. Although
there can be no assurances, the Company believes that declining reimbursement
trends can be offset with increased utilization so that such trends will not
have a significant negative impact on the Company's operating results or its
liquidity in the future.
The Company will continue to pursue opportunities in its
fee-for-service business; however, in view of the historical unprofitability and
uncertainty regarding fee-for-service arrangements, the Company expects to sell
equipment used in its fee-for-service business as the related hospital contracts
expire. As such, the Company believes that revenues from its fee-for-service
business will decline.
Management believes that the actions taken in 1994 to terminate
unprofitable contracts, to sell underperforming assets and to renegotiate
various maintenance and lease agreements have positioned the Company to continue
operating given the current reimbursement dynamics of the diagnostic imaging
industry. In order to improve its financial position, the Company will continue
to evaluate its operating costs and reduce spending as appropriate. In addition,
the Company is negotiating to restructure its convertible debenture debt on
terms more favorable to the Company. There can be no assurances, however, that
such actions regarding spending reductions or negotiations to restructure debt
arrangements will be sufficient to provide adequate cash to sustain the
operations of the Company.
Although the Company cannot accurately anticipate the effect of
inflation on its operations, it does not believe that inflation has had, or is
likely in the foreseeable future to have, a material impact on its net sales or
results of operations.
12
<PAGE> 13
RESULTS OF OPERATIONS
1994 COMPARED TO 1993
REVENUES FROM MEDICAL SERVICES. Revenues declined $8.9 million from $36 million
in 1993 to $27.1 million in 1994 primarily due to the Company's sale of
underperforming assets and termination of certain unprofitable leases and
contracts used in its fee-for-service business. Revenues declined $1.5 million
from $29.8 million in 1993 to $28.3 million in 1994 primarily due to declining
trends in both reimbursement and utilization experienced at its DMCs. As noted
above, a number of factors exist that could have an impact on the Company's
future revenues, including declining prices and an oversupply in the diagnostic
equipment market, declining trends in reimbursement and competition in the
healthcare industry.
REVENUES FROM EQUIPMENT AND MEDICAL SUITE SALES. Revenues from equipment and
medical suite sales decreased from $3 million in 1993 to $1.9 million in 1994.
The decrease in sales is due to the quantity and type of equipment and medical
suites sold and will vary accordingly. The Company intends to sell equipment and
its remaining inventory of medical suites in the future, but such sales are
subject to market conditions and there can be no assurances that such sales will
or will not occur.
COSTS OF MEDICAL SERVICES. Costs of medical services decreased from $42.8
million (65% of medical services revenues) in 1993 to $33.7 million (61% of
medical services revenues) in 1994. Costs decreased due to termination of leases
and contracts, sales of fee-for-service equipment and from actions taken by the
Company to reduce spending. These actions included further reductions in
marketing and administrative personnel and renegotiations of various maintenance
and lease agreements.
COSTS OF EQUIPMENT AND MEDICAL SUITE SALES. Costs of equipment and medical suite
sales decreased from $2.7 million in 1993 to $1.7 million in 1994. The decrease
in costs is directly related to the quantity and type of equipment and medical
suites sold and will vary accordingly.
MARKETING, GENERAL AND ADMINISTRATIVE EXPENSES. Marketing, general and
administrative expenses decreased from $7.9 million (12% of medical services
revenues) in 1993 to $5.6 million (10% of medical services revenues) in 1994.
The decrease in costs resulted from reductions in administrative and marketing
personnel and other spending reductions, offset by severance incurred in the
fourth quarter of 1994 of $894,000 relating to the resignation of the Company's
former Chief Executive Officer.
PROVISION FOR DOUBTFUL ACCOUNTS. Provision for doubtful accounts decreased from
$2.6 million (4% of medical services revenues) in 1993 to $1.3 million (2% of
medical services revenues) in 1994 based on management's evaluation of patient
accounts receivables at its DMCs.
DEPRECIATION AND AMORTIZATION. Depreciation and amortization decreased from $14
million in 1993 to $12.7 million in 1994. This decrease was primarily due to the
sale of underperforming assets and termination of certain unprofitable leases
used in the fee-for-service business and the 1993 fourth quarter non-cash charge
to write off goodwill related to prior years' acquisitions.
INTEREST EXPENSE AND INCOME. Interest expense decreased from $6.3 million in
1993 to $5.1 million in 1994. The decrease in interest expense resulted from the
sale of underperforming assets and termination of certain unprofitable leases
used in the fee-for-service business. Interest income decreased from $.7 million
in 1993 to $.5 million in 1994.
SPECIAL CHARGE. Operating results in 1993 included a non-cash charge of
approximately $21.5 million to write off goodwill associated with prior years'
acquisitions and a non-cash charge of $2 million to increase reserves
established to reflect uncertainty regarding the realization of certain other
assets. There were no special charges recorded in 1994.
13
<PAGE> 14
MINORITY INTEREST IN NET INCOME/LOSS OF CONSOLIDATED PARTNERSHIPS. Minority
interest in the consolidated partnerships increased from a $.2 million minority
interest in net loss in 1993 to a $.1 million minority interest in net income in
1994 due to improved performance of certain DMC's with significant minority
ownership.
INCOME TAXES. At December 31, 1994, the Company had net operating loss
carryforwards of approximately $30.9 million for Federal income tax purposes,
therefore no income tax expense was recorded in 1994.
EXTRAORDINARY GAIN. In 1994, the Company recorded a non-cash extraordinary gain
of $1.3 million resulting from the forgiveness of debt related to certain MRI
equipment.
1993 COMPARED TO 1992
REVENUES FROM MEDICAL SERVICES. Revenues decreased from $74.3 million in 1992 to
$65.8 million in 1993 due to the sale of underperforming assets used in its
fee-for-service business and lower reimbursement of diagnostic imaging services.
REVENUES FROM EQUIPMENT AND MEDICAL SUITE SALES. Revenues decreased from $10.3
million in 1992 to $3 million in 1993. The decrease in revenues is directly
related to the quantity and type of equipment and medical suites sold and will
vary accordingly. The Company intends to sell additional equipment and medical
suites in the future, but such sales are subject to market conditions and there
can be no assurance that such sales will or will not occur.
COSTS OF MEDICAL SERVICES. Costs decreased from $50.5 million (68% of medical
services revenues) in 1992 to $42.8 million (65% of medical services revenues)
in 1993. The reduction in costs as a percentage of revenue was partially offset
by lower revenues. Cost reductions in 1993 resulted from aggressive actions
taken by the Company to reduce spending. These actions included: the closure of
division offices and relocation and consolidation of related functions to the
corporate office; substantial reduction in administrative employees; and
implementation of 10% salary reductions for upper level management and pay
freezes for substantially all employees.
COSTS OF EQUIPMENT AND MEDICAL SUITE SALES. Costs decreased from $9.6 million in
1992 to $2.7 million in 1993. The difference in costs is directly related to the
quantity and type of equipment and medical suites sold and will vary
accordingly.
MARKETING, GENERAL AND ADMINISTRATIVE EXPENSES. Marketing, general and
administrative expenses decreased from $11.8 million (16% of medical services
revenues) in 1992 to $7.9 million (12% of medical services revenues) in 1993.
The decrease in costs from 1992 to 1993 resulted from the closure of offices,
reductions in the number of employees and other spending reductions which took
place during 1993.
PROVISION FOR DOUBTFUL ACCOUNTS. Provision for doubtful accounts decreased from
$2.9 million (4% of medical services revenues) in 1992 to $2.6 million (4% of
medical services revenues) in 1993.
DEPRECIATION AND AMORTIZATION. Depreciation and amortization increased from
$12.7 million in 1992 to $14 million in 1993. This increase is primarily due to
equipment and building additions at several of the DMC's in 1993.
INTEREST EXPENSE AND INCOME. Interest expense decreased from $7.8 million in
1992 to $6.3 million in 1993. This decrease resulted from the sale and return of
certain underperforming assets and the impact of the interest rate reduction
14
<PAGE> 15
on convertible subordinated debt from 12% to 6% which was effective November 1,
1992. Interest income decreased from $1.4 million in 1992 to $.7 million in 1993
due to the termination of certain sales-type leases.
LITIGATION SETTLEMENT. The court approved the settlement of the class action
lawsuit brought in 1991 against the Company and certain of its former officers
(see Note 11 to MICA's consolidated financial statements).
SPECIAL CHARGE. Operating results in 1993 include a non-cash charge of
approximately $21.5 million to write off goodwill associated with prior years'
acquisitions and a non-cash charge of $2 million to increase reserves
established to reflect uncertainty regarding the realization of certain other
assets. Operating results in 1992 include a special charge of $10 million to
establish reserves for uncertainty regarding the collectability of payments for
assets sold under sales-type lease arrangements in 1991 and to adjust certain
assets and accounts receivable to net realizable value. The 1992 special charge
also includes relocation and severance costs associated with the closing of its
division office in Illinois.
MINORITY INTEREST IN NET INCOME/LOSS OF CONSOLIDATED PARTNERSHIPS. Minority
interest in the consolidated partnerships decreased from a $377,000 net income
in 1992 to a $178,000 net loss in 1993. This decrease in net income is primarily
due to a full year's impact of losses in 1993 from certain DMC's opened in late
1992 and lower volume at one of the consolidated DMC's.
INCOME TAXES. At December 31, 1993, the Company had net operating loss
carryforwards of approximately $32.8 million for Federal income tax purposes,
therefore no income tax expense was recorded in 1993.
Item 8. Financial Statements and Supplementary Data
The Consolidated Financial Statements and supplementary data of the
Company required by this item are set forth at the pages indicated in Item 14
(a) (1).
Item 9. Changes in and Disagreements with Accountants
on Accounting and Financial Disclosure
None.
15
<PAGE> 16
PART III
Item 10. Directors and Executive Officers of the
Registrant
The Board of Directors. Directors serve for a term of one year and
until their successors are duly elected and qualified. The Company's By-Laws
currently provide for a Board of not less than five members nor more than nine
members, with the exact number of directors fixed from time to time by the
Board. The Board has fixed the number of directors at six. During the fiscal
year ended December 31, 1994, the Company's Board of Directors held nine
meetings. Each director attended at least 75% of all Board meetings during such
periods as he was a Board member.
Set forth below are the directors of the Company.
<TABLE>
<CAPTION>
Year First
Name Age Position Elected To Serve
-----------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Robert S. Muehlberg 41 Chairman of the Board, President, 1994
Chief Executive Officer and Director
Denise L. Sunseri 36 Vice President, Chief Financial 1995
Officer, Secretary and Director
E. Keene Wolcott 64 Director 1991
Keith R. Burnett, M.D. 42 Director 1993
Samuel L. Mayhugh, Ph.D. 56 Director 1993
Robert A. Prosek 50 Director 1994
</TABLE>
Robert S. Muehlberg has been Chief Executive Officer and Chairman of
the Board of Directors of the Company since February 1995, and also holds the
position of President/Chief Operating Officer which he assumed in November 1994.
Mr. Muehlberg previously held the positions of Executive Vice President, Senior
Vice President and Vice President, Operations since joining the Company in
February 1985. Prior to joining the Company, Mr. Muehlberg was Operations
Manager at International Imaging, Inc., a provider of mobile and free-standing
diagnostic imaging centers, from 1983 to 1985, and Area Manager for AMI/DSI, a
provider of mobile diagnostic imaging services, from 1980 to 1983. Mr. Muehlberg
holds a Bachelor's degree in Health Science from the University of Missouri and
a Master's degree in Business Administration from NOVA University.
Denise L. Sunseri has been Chief Financial Officer and Secretary of
the Company since June 1993 and a director of the Company since February 1995.
She joined the Company as Director of Financial Reporting in 1989 and served as
Vice President and Corporate Controller from 1991 to June 1993. Prior to joining
MICA, Ms. Sunseri held various positions between 1981 and 1989 in the Auditing
and Financial Services division of the accounting firm of Arthur Andersen & Co.
Ms. Sunseri is a CPA and holds a Bachelor's degree in Business Administration
from the University of Portland.
E. Keene Wolcott, a Director of the Company since February 1991, has
for the past 20 years been President of Wolcott Investments, Inc., a private
investment company. Mr. Wolcott is also a Director of the Price REIT, Inc., a
real estate investment trust. From 1969 to 1973, he was the Chief Executive
Officer of The Colorado Corporation which managed investor funds in oil and gas
exploration, and prior thereto was a Senior Vice President of the securities
broker Hayden, Stone and Company. He received his Bachelor of Science degree
from San Diego State University in 1953.
Keith R. Burnett, M.D., a Director of the Company since 1993, is the
Medical Director of two of the Company's medical centers: Medical Imaging Center
of Huntington Beach since 1988 and Laguna Niguel MRI Center since 1992. He is
also Medical Director of Medical Imaging Services, a California network of
imaging services. He has been an Assistant Clinical Professor of Radiology at
the University of California at Irvine since 1985 and a consultant in Nuclear
Medicine, Veterans Medical Center since 1988. He is Chairman of the Examination
Committee of the Registry of Magnetic Resonance Technologists (RMRIT) and a
member of the Advisory Council on MRI and Chiropractic Research at the Los
Angeles College of Chiropractic. Dr. Burnett received his Bachelor of Arts
degree in Human Biology
16
<PAGE> 17
from Stanford University in 1974 and his Doctor of Medicine degree from
Creighton University in 1978. Dr. Burnett is board certified in Radiology and
Nuclear Medicine and a Diplomate of the America Board of Radiology.
Samuel L. Mayhugh, Ph.D., a Director of the Company since 1993, served
the Company as its Acting Chairman of the Board and Chief Executive Officer for
a three month period following the resignation of the Company's former Chairman
of the Board and Chief Executive Officer on November 14, 1994. Dr. Mayhugh
founded and developed Integrated Behavioral Health, a full-service managed
behavioral health firm, in 1989. Prior thereto he had also founded and served as
Chairman/President and CEO/COO of LifeLink. LifeLink is a fully insured managed
behavioral health care company. Dr. Mayhugh is a lecturer, consultant and author
in the field of managed behavioral health care. He is a Fellow of the American
Board of Psychology, Fellow and Diplomate of the American Association of Medical
Psychotherapists, Member of the American Psychological Association and the
California Psychological Association. Dr. Mayhugh received his Bachelor of Arts
degree in Biological Sciences from Olivet University in 1961, a Master's degree
in Counseling Psychology from Purdue University in 1965 and a Ph.D. in
Psychological Services from Indiana State University in 1969.
Robert A. Prosek, a director since August 1994, has been involved in
the medical industry for the past 25 years. President and CEO of Allergy Clinics
of America, Inc., a chain of outpatient asthma and allergy clinics, since June
1994, he was President and CEO of CarePartners, Inc., a homecare infusion
company, from 1991 to 1993. From 1989 to 1991, Mr. Prosek was President of
Psicor, Inc., a leading provider of cardiovascular services and technology to
hospitals. From 1968 to 1989, he was involved with various healthcare companies
in management and executive capacities. He serves on the Board of Directors of
several private companies. Mr. Prosek received his Bachelor of Science in
Marketing Management from Southern Illinois University in 1968 and a Master's of
Business Administration from Suffolk University in 1980.
The Committees. The Company has a Compensation/Stock Option Committee
and an Audit Committee. The Compensation/Stock Option Committee is responsible
for determining the specific forms and levels of compensation of the Company's
executive officers and administering the Company's Stock Option Plans for
officers, directors, key employees and consultants of the Company. During 1994,
the Committee of Messrs. Samuel L. Mayhugh, Ph.D. (Chairperson), Sidney R.
Knafel (former member of the Board of Directors) and Keith R. Burnett, M.D. met
once and all Committee members were present. Subsequent to that meeting, the
Committee was changed to consist of Messrs. Mayhugh (Chairperson) and Robert A.
Prosek. This Committee also met once during 1994 and both members of the
Committee were present. Subsequent to yearend, the Board changed the composition
of the Compensation/Stock Option Committee to three Directors, Messrs. Burnett
(Chairperson), E. Keene Wolcott and Prosek.
The Audit Committee is responsible for meeting with the Company's
financial management and independent auditors to review the work of each and to
ensure that each is properly discharging its responsibilities. The independent
auditors have free access to the Audit Committee, without management
representatives present, to discuss results of their audit and their opinions of
the adequacy of the internal controls and quality of financial reporting. The
Audit Committee recommends to the Board of Directors the election of the firm of
independent auditors to audit the Company's financial statements. During 1994,
the Committee of Messrs. Knafel (Chairperson and former member of the Board of
Directors), Wolcott and Burnett met twice and all members of the Committee were
present at both meetings. Subsequent to year end, the Board changed the
composition of the Audit Committee to three Directors, Messrs. Wolcott
(Chairperson), Burnett and Prosek.
The Company does not have an executive or nominating or similar
committee. The Board of Directors generally acts in its entirety upon matters
which might otherwise be the responsibility of such committees.
Compensation of Directors. Directors of the Company (other than
employees) currently receive $3,000 for each meeting attended for their services
as directors, and are reimbursed for out-of-pocket expenses of attending
meetings. On March 24, 1993, the Board of Directors voluntarily agreed to
indefinitely defer $2,000 per meeting. Effective February 28, 1995 the Directors
waived all deferred fees and reinstated the $3,000 fee per meeting.
17
<PAGE> 18
Also on February 28, 1995, the Directors of the Company were granted 25,000
warrants to purchase Common Stock at the day's closing price of $.81 per share.
The Chairpersons of the Compensation/Stock Option Committee and Audit Committee
receive an additional $2,000 and $4,000 respectively, for their service as
Chairperson.
Executive Officers. The executive officers of the Company, together
with the year in which they were appointed to their current positions, are set
forth below.
<TABLE>
<CAPTION>
Name Age Position Year
----------------------------------------------------------------------------------------
<S> <C> <C> <C>
Robert S. Muehlberg 41 Chairman of the Board, President 1995
and Chief Executive Officer
Denise L. Sunseri 36 Vice President, Chief Financial 1993
Officer and Secretary
</TABLE>
Information concerning Mr. Muehlberg and Ms. Sunseri is set forth above
under "The Board of Directors."
Compliance with the Securities Exchange Act of 1934. Section 16(a) of
the Securities Exchange Act of 1934 requires the Company's directors and
officers and persons who own more than 10% of a registered class of the
Company's equity securities to file reports of ownership and changes in
ownership with the Securities and Exchange Commission ("SEC"). Directors and
officers and greater than 10% stockholders are required by SEC regulation to
furnish the Company with copies of the reports they file. Based solely upon a
review of the copies of such reports and the written representations from
certain persons that certain reports were not required to be filed by such
persons, the Company believes that all its directors, officers and greater than
10% beneficial owners complied with all filing requirements applicable to them
with respect to transactions during fiscal 1994.
Item 11. Executive Compensation
Summary Compensation Table. The following table discloses compensation
received by the executive officers who served the Company during 1994 for
services provided for the three fiscal years ended December 31, 1994.
<TABLE>
<CAPTION>
Long-Term
Annual Compensation Compensation Awards All Other
------------------- ------------------- ---------
Name and Principal Position Year Salary ($) Bonus ($) Securities Underlying Options (#) Compensation ($)
---------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
Robert S. Muehlberg 1994 148,450 25,000 200,000 5,612(1)
Chairman of the Board, 1993 148,628 20,000 60,000 6,256(1)
President and Chief 1992 157,441 15,000 50,000 3,309(1)
Executive Officer
Denise L. Sunseri 1994 142,200 25,000 100,000 5,882(2)
Vice President, Chief 1993 135,385 15,000 60,000 5,497(2)
Financial Officer and Secretary 1992 111,239 10,000 30,000 3,206(2)
Former Officers
Antone J. Lazos 1994 249,223(3) 110,813(4) 400,000 823,427(5)
Former Chairman of 1993 241,806 -- 200,000 79,984(5)
the Board and Chief 1992 259,594 -- 150,000 36,092(5)
Executive Officer
Samuel L. Mayhugh 1994 45,000(6) -- -- 43,250(7)
Former Acting Chief
Executive Officer
</TABLE>
18
<PAGE> 19
(1) The amounts disclosed in this column include payments under the
Company's medical reimbursement policy of $1,036 for 1994, $2,474 for
1993 and $404 for 1992; the Company's matching 401(k) employer
contribution of $3,469 for 1994, $2,752 for 1993, and $2,905 for 1992;
and $1,107 for 1994 and $1,029 for 1993 in premiums for a personal
long-term disability policy. Mr. Muehlberg became the Chairman of the
Board and Chief Executive Officer in February 1995. Prior to that time,
Mr. Muehlberg served as the Company's President and Chief Operating
Officer.
(2) The amounts disclosed in this column include payments under the
Company's medical reimbursement policy of $1,699 for 1994, $1,706 for
1993 and $780 for 1992; the Company's matching 401(k) employer
contribution of $3,344 for 1994, $3,008 for 1993, and $2,426 for 1992;
and $839 for 1994 and $784 for 1993 in premiums for a personal
long-term disability policy.
(3) This amount represents salary and unused vacation paid through November
14, 1994, the date of Mr. Lazos' resignation from the Company.
(4) This amount represents a bonus of $75,000 paid in 1994 for 1993
performance and $35,813 which was paid in 1994 as a bonus to reimburse
Mr. Lazos for taxes due on medical benefits received in 1993.
(5) The amounts disclosed in this column include $20,000 in premiums for a
personal life insurance policy for each of the years indicated;
payments under the Company's medical reimbursement policy of $32,029
for 1994, $49,989 for 1993 and $16,092 for 1992; the Company's matching
401(k) employer contributions of $4,620 for 1994 and $1,263 for 1993;
$5,356 for 1994 and $5,365 for 1993 in premiums for a personal
long-term disability policy; reimbursement for certain personal
benefits of $23,791 for 1994 and $3,367 for 1993; reimbursement for
moving expenses of $38,431 in 1994; $30,000 for three months consulting
services following his resignation; and $669,200 in lump sum severance
compensation pursuant to Mr. Lazos' agreement with the Company, half of
which was paid in November 1994 and the other half of which was paid in
January 1995.
(6) The amount disclosed in this column represents $10,000 per month paid
for services performed as Acting Chief Executive Officer for three
months starting in November 1994 and $15,000 paid as director fees.
(7) The amount disclosed in this column includes $43,250 paid as consulting
fees.
Option Grants. The following table provides information on option
grants to the named executive officers during 1994:
<TABLE>
<CAPTION>
Potential Realizable
Individual Grants Value at Assumed
------------------------------------------------------------ Annual Rates of
Percentage of Stock Price
Number of Total Options Appreciation for
Securities Granted to Exercise Option Term (3)
Underlying Options Employees in Price Expiration ---------------------
Name Granted (#) Fiscal Year ($/Share) Date 5% ($) 10% ($)
---------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
Robert S. Muehlberg 100,000(1) 12.4% $0.688 1/1/99 $19,000 $42,100
100,000(2) 12.4% $0.470 9/6/99 $13,100 $28,800
Denise L. Sunseri 100,000(1) 12.4% $0.688 1/1/99 $19,000 $42,100
Former Officers
Antone J. Lazos(6) 100,000(4) 12.4% $0.688 11/14/94(4) -- --
150,000(4) 18.7% $0.470 11/14/94(4) -- --
150,000(5) 18.7% $0.470 11/14/95(5) $19,650 $43,200
Samuel L. Mayhugh, Ph.D. -- -- -- -- -- --
</TABLE>
19
<PAGE> 20
(1) Options become exercisable for one third of the shares granted on each
of the first three anniversaries of the date of grant. In the event
that the Company and/or its shareholders enter into a binding agreement
or adopt a plan to implement a dissolution, liquidation,
reorganization, merger or consolidation of the Company with one or more
corporations as a result of which the Company is not the surviving
entity, or upon a sale of substantially all the property of the
Company, the exercise date of any outstanding Options shall accelerate
and such Options shall become immediately exercisable.
(2) Options become exercisable for one fourth of the shares granted on each
of the first four anniversaries of the date of grant. In the event that
the Company and/or its shareholders enter into a binding agreement or
adopt a plan to implement a dissolution, liquidation, reorganization,
merger or consolidation of the Company with one or more corporations as
a result of which the Company is not the surviving entity, or upon a
sale of substantially all the property of the Company, the exercise
date of any outstanding Options shall accelerate and such Options shall
become immediately exercisable.
(3) Potential realizable value is based on an assumption that the stock
price of the common stock appreciates above the exercise price at the
annual rate shown (compounded annually) from the date of grant until
the end of the five year option term. These numbers are calculated
based on the requirements promulgated by the Securities and Exchange
Commission and do not reflect the Company's estimate of future stock
price growth.
(4) Pursuant to Mr. Lazos' severance agreement with the Company, unvested
options were forfeited upon his resignation from the Company on
November 14, 1994.
(5) These options became 100% vested on the September 6, 1994 grant date.
Pursuant to Mr. Lazos' severance agreement with the Company, all vested
options as of the date of resignation are exercisable until November
14, 1995.
(6) The information included in this table does not include options to
purchase 100,000 and 66,000 shares of Common Stock at $3.75 and $.625,
respectively, which were granted to Mr. Lazos in previous years and for
which the exercise period was extended for one year pursuant to his
severance agreement executed on February 9, 1995.
Option Exercises and Fiscal Year-end Values. None of the named
executive officers exercised any stock options during fiscal 1994. The following
table provides information on the value of such executive officers' unexercised
options at December 31, 1994.
<TABLE>
<CAPTION>
Shares Number of Securities Value of Unexercised
Acquired Value Underlying Options In-the-Money Options
on Exercise Realized at Fiscal Year-end (#) at Fiscal Year-End ($)
---------------------------- ------------------------------
Name (#) $ Exercisable Unexercisable Exercisable Unexercisable
----------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
Robert S. Muehlberg -- -- 53,333 256,667 $ 2,500 $39,200
Denise L. Sunseri -- -- 40,000 150,000 $ 2,500 $11,200
Former Officers
Antone J. Lazos -- -- 316,000 -- $50,250 --
Samuel L. Mayhugh, Ph.D -- -- -- -- -- --
</TABLE>
Employment Contracts and Severance Arrangements.
EMPLOYMENT CONTRACTS. As an incentive for their continued efforts on
behalf of the Company, the Board of Directors has entered into employment
contracts with Mr. Muehlberg and Ms. Sunseri which provide that they will be
20
<PAGE> 21
paid the equivalent of one year's salary and employee benefits in the event that
their employment by the Company is involuntarily terminated or if there is a
change in the control of the Company and they should elect not to remain
employed after such change in control.
SEVERANCE ARRANGEMENTS. The Company's founder, Chairman of the Board
and Chief Executive Officer since inception, Antone J. Lazos, resigned on
November 14, 1994. By the terms of an employment separation agreement between
the Company and Mr. Lazos entered into in December 1990, as amended in November
1994, and finalized in a severance settlement agreement and release of claims
entered into in February 1995, the Company paid Mr. Lazos following his
resignation a lump sum of $669,200 (representing two times his annual salary of
$250,000, two times his annual car allowance of $9,600 and two times his prior
year's bonus of $75,000) and $36,282 for vacation pay accrued as of November 14,
1994. The $669,200 amount was paid to Mr. Lazos in two installments, 50% in
November 1994 and the remaining 50% in January 1995. The Company also agreed to
provide Mr. Lazos with continued health coverage and other benefits through
December 31, 1996 and to retain Mr. Lazos as a consultant to the Company for
approximately three months following his resignation at a fee of $10,000 per
month. In addition, the Company agreed to extend the exercise period of Mr.
Lazos' vested options to purchase 316,000 shares of Common Stock until November
14, 1995. As part of such severance agreement, the Company and Mr. Lazos
released each other from any and all claims related to any transactions between
them, including any claims related to Mr. Lazos' employment with the Company
(other than claims based solely on acts of dishonesty or fraudulent conduct).
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION. During
fiscal 1994, the Compensation/Stock Option Committee of the Company's Board of
Directors initially consisted of Messrs. Samuel L. Mayhugh, Ph.D., Sidney R.
Knafel and Keith R. Burnett, M.D. Subsequently, the Committee was changed to
consist of Messrs. Mayhugh and Robert A. Prosek. Dr. Mayhugh served as Acting
Chief Executive Officer of the Company for three months following the
resignation of the Company's then Chief Executive Officer, Mr. Antone J. Lazos,
in November 1994. Dr. Burnett is a principal and officer of Magnetic Imaging
Medical Group, a California medical corporation ("MIMG"), which provides
radiology and other medical services for the Company's Diagnostic Medical
Centers located in Long Beach, Huntington Beach, Laguna Niguel and Downey,
California. In 1994, the Company's share of revenues collected was $702,000,
$497,000, $187,000 and $2,000, respectively. See "Certain Relationships and
Related Transactions".
Item 12. Security Ownership of Certain Beneficial
Owners and Management
As of March 21, 1995, the following shareholders are the only
shareholders who are known to the Company to be beneficial owners of more than
five percent (5%) of the Company's voting securities.
<TABLE>
<CAPTION>
Amount and Nature
of Beneficial Percentage of
Name and Address of Beneficial Owner Ownership(1) Common Stock
--------------------------------------------------------------------------------------------------------------
<S> <C> <C>
Metropolitan Life Insurance Co. 2,500,000(2) 17.1%(2)
One Madison Avenue
New York, NY 10010
Grace Brothers, Ltd. 666,666(2) 5.2%(2)
1000 West Diversey Parkway, Suite 233
Chicago, IL 60614
Steel Partners, II, L.P. 677,519(3) 5.6%
759 Lexington Avenue, 27th Floor
New York, NY 10022
</TABLE>
(1) For purposes of this table, a person is deemed to have "beneficial
ownership" of any security that such person has
21
<PAGE> 22
the right to acquire within 60 days after March 21, 1995.
(2) The Company's Convertible Debentures due April 1999 bear interest at the
rate of 6% per annum and are convertible at any time into one share of
Common Stock for each $3.00 of principal amount of Debenture. The Amount
and Percentage of Common Stock in the table represents beneficial
ownership as if the Debentures had been converted to Common Stock.
(3) The information in the table is taken from a filing with the SEC on
Schedule 13D made by Steel Partners, II, L.P. as of March 17, 1995
reporting beneficial ownership.
Section 16(a) of the Securities Exchange Act of 1934 requires the
Company's officers and directors and persons who own more than 10% of the
Company's Common Stock to file reports of ownership and changes in ownership
with the Securities and Exchange Commission. These reporting persons are also
required to furnish the Company with copies of all reports they file. Based
solely on its review of the copies of such forms received by it, or written
representation from certain reporting persons that no Forms 5 were required for
those persons, the Company believes that during its 1994 fiscal year all filing
requirements applicable to its officers, directors and greater than 10%
shareholders were complied with.
Set forth below are names and beneficial shareholdings, as of March 21,
1995 of (i) the Directors of the Company, (ii) each executive officer named in
the Summary Compensation Table appearing herein, and (iii) all executive
officers and directors as a group.
<TABLE>
<CAPTION>
No. of Shares of Common Percentage of Common
Name Stock Owned Beneficially Stock Outstanding
------------------------------------------------------------------------------------------------------------------
<S> <C> <C>
Robert S. Muehlberg 10,000 .08%
Denise L. Sunseri -- --
E. Keene Wolcott 70,000(1) .57%
Keith R. Burnett, M.D. 63,723(2) .53%
Samuel L. Mayhugh, Ph.D. 60,100(2) .50%
Robert A. Prosek 60,000(3) .49%
All Officers and Directors as a Group (6 persons) 263,823(4) 2.17%
Former Officer
Antone J. Lazos 96,000(5) .79%
</TABLE>
----------
(1) Includes presently exercisable warrants to purchase 35,000 and 25,000
shares of Common Stock at $3.75 and $.81 per share, respectively, issued
for service as a director.
(2) Includes presently exercisable warrants to purchase 35,000 and 25,000
shares of Common Stock at $.88 and $.81 per share, respectively, issued
for service as a director.
(3) Includes presently exercisable warrants to purchase 35,000 and 25,000
shares of Common Stock at $.56 and $.81 per share, respectively, issued
for service as a director.
(4) Includes presently exercisable warrants to purchase an aggregate of
240,000 shares of Common Stock at $.56 to $3.75 per share.
(5) Antone J. Lazos, formerly the Chairman of the Board and Chief Executive
Officer of the Company until his resignation on November 14, 1994,
beneficially owns 96,000 shares of Common Stock.
The Company believes that each of the stockholders listed in the table
above has sole voting and dispositive power over all shares owned.
22
<PAGE> 23
Item 13. Certain Relationships and Related Transactions
Dr. Keith R. Burnett, a director of the Company, is a principal and
officer of Magnetic Imaging Medical Group, a California medical corporation
("MIMG"), which provides radiology and other medical services for the Company's
Diagnostic Medical Centers located in Long Beach, Huntington Beach, Laguna
Niguel and Downey, California. MIMG is a Co-General Partner of the center in
Long Beach. Dr. Burnett serves as the Medical Director for the facilities in
Huntington Beach and Laguna Niguel. The Management, Licensing and Facilities
Agreement between the respective Centers and MIMG ("Agreements") provides that
MICA will receive for services rendered: 77.5% of the revenues collected at Long
Beach Medical Imaging Clinic, 80% of the revenues collected at Medical Imaging
Center of Huntington Beach and Laguna Niguel MRI Center, and 82% at Downey MRI
Center. Pursuant to the Agreements, the balance of the amounts collected is
retained by MIMG as their fee. In 1994, revenues collected from Long Beach
Medical Imaging Clinic were $3,027,000; from Medical Imaging Center of
Huntington Beach were $2,565,000; from Laguna Niguel MRI Center were $981,000;
and from Downey MRI Center were $331,000.
PART IV
Item 14. Exhibits, Financial Statements and Reports on
Form 8-K
(a) (1) Financial Statements.
The consolidated financial statements required by this item are
submitted as part of this Annual Report in a separate section beginning on Page
F-1 of this report.
Consolidated Financial Statements of Medical Imaging
Centers of America, Inc. Page
Report of Ernst & Young LLP, Independent Auditors F-1
Consolidated Balance Sheets at
December 31, 1994 and 1993 F-2
Consolidated Statements of Operations for the
three years ended December 31, 1994 F-3
Consolidated Statements of Shareholders' Equity (Net Capital
Deficiency) for the three years ended December 31, 1994 F-4
Consolidated Statements of Cash Flows for the
three years ended December 31, 1994 F-5
Notes to Consolidated Financial Statements F-7
(b) Reports on Form 8-K.
There were no reports on Form 8-K filed by the Registrant during the
fourth quarter of the fiscal year ended December 31, 1994.
(c) Exhibits.
The exhibits listed on the accompanying Index to Exhibits are filed as
part of this Annual Report.
23
<PAGE> 24
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
Sequentially
Numbered
Number Description Page
--------------------------------------------------------------------------------------------------------
<S> <C> <C>
3.1 I Restated Articles of Incorporation
3.2 II Bylaws
4.1 III Trust Indenture, Debenture due April 1999
4.2 III Debenture due April 1999
4.3 IV Amendments to Trust Indenture dated April 1993 and February 1994
4.4 II Common Stock Purchase Warrant Agreement
4.5 V Shareholders' Rights Agreement
10.1 VI 1983 Employee Stock Option Plan
10.2 VI 1984 Employee Stock Option Plan (Nonqualified)
10.3 VI 1985 Employee Incentive Stock Option Plan
10.4 VII Credit Line Agreement with Harris Trust and Savings Bank
10.5 IV General Electric Loan Restructuring Agreement dated May 14, 1993
10.6 Employment Agreements of Robert S. Muehlberg and Denise L. Sunseri
10.7 Severance Agreement with Antone J. Lazos dated February 9, 1995
10.8 VIII Management, Licensing and Facilities Agreement
for Company's Huntington Beach Medical Imaging Center
10.8 VIII Management, Licensing and Facilities Agreement
for Company's Laguna Niguel Medical Center
21 Subsidiaries List
23 Consent of Ernst & Young LLP, Independent Auditors
</TABLE>
24
<PAGE> 25
INDEX TO EXHIBITS, continued
I Indicates the exhibit is incorporated by reference from
Registrant's Form S-1 Registration Statement (Reg.
No. 33-15160) filed June 18, 1987.
II Indicates the exhibit is incorporated by reference from
Registrant's Form S-1 Registration Statement (Reg.
No. 2-91368) filed on May 25, 1984, as amended.
III Indicates the exhibit is incorporated by reference from
Registrant's Form 8-K Report dated May 10, 1989.
IV Indicates the exhibit is incorporated by reference from
Registrant's Form 10-K Report for the year ended
December 31, 1993.
V Indicates the exhibit is incorporated by reference from
Registrants' Form 8-K Report dated October 2, 1991.
VI Indicates the exhibit is incorporated by reference from
Registrant's Form S-8 Registration Statement (Reg.
No. 33-29917) filed on July 12, 1989.
VII Indicates the exhibit is incorporated by reference from
Registrant's Form 10-K Report for the year ended
December 31, 1991.
VIII Indicates the exhibit is incorporated by reference from
Registrant's Form 10-K Report for the year ended
December 31, 1992.
The financial statements listed in the accompanying Index to Financial
Statements are filed as a part of this Annual Report.
25
<PAGE> 26
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
Dated: August 31, 1995
MEDICAL IMAGING CENTERS OF AMERICA, INC.
By: /s/ Robert S. Muehlberg
-----------------------
Robert S. Muehlberg, Chairman of the Board,
President and Chief Executive Officer
26
<PAGE> 27
Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
<TABLE>
<CAPTION>
Signature Title Date
--------- ----- ----
<S> <C> <C> <C>
By: /s/ Robert S. Muehlberg Chairman of the Board of Directors, August 31, 1995
----------------------- President and Chief Executive
Robert S. Muehlberg Officer (Principal Executive
Officer)
By: /s/ Denise L. Sunseri Chief Financial Officer, August 31, 1995
--------------------- Secretary (Principal
Denise L. Sunseri Financial and Accounting
Officer) and Director
By: /s/ E. Keene Wolcott Director August 31, 1995
--------------------
E. Keene Wolcott
By: /s/ Keith R. Burnett Director August 31, 1995
--------------------
Keith R. Burnett, M.D.
By: /s/ Robert G. Ricci, D.O. Director August 31, 1995
-------------------------
Robert G. Ricci, D.O.
</TABLE>
27
<PAGE> 28
REPORT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
The Board of Directors and Shareholders
Medical Imaging Centers of America, Inc.
We have audited the accompanying balance sheets of Medical Imaging Centers of
America, Inc. as of December 31, 1994 and 1993, and the related consolidated
statements of operations, shareholders' equity (net capital deficiency), and
cash flows for each of the three years in the period ended December 31, 1994.
These financial statements are the responsibility of the Company's management.
Our responsibility is to express an opinion on these financial statements based
on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the consolidated financial statements. An audit
also includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our
opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the consolidated financial position of Medical
Imaging Centers of America, Inc. at December 31, 1994 and 1993, and the
consolidated results of its operations and its cash flows for each of the three
years in the period ended December 31, 1994 in conformity with generally
accepted accounting principles.
ERNST & YOUNG LLP
San Diego, California
February 17, 1995
F-1
<PAGE> 29
MEDICAL IMAGING CENTERS OF AMERICA, INC.
CONSOLIDATED BALANCE SHEETS
<TABLE>
<CAPTION>
December 31,
------------
(in thousands except share information) 1994 1993
-------------------------------------------------------------------------------------------------------------------
<S> <C> <C>
ASSETS:
Current assets:
Cash and cash equivalents (includes restricted cash of
$832 in 1994 and $853 in 1993) $ 8,524 $ 8,182
Trade and notes receivable, net 9,524 12,749
Prepaid expenses and other current assets 1,611 1,897
-------------------------
Total current assets 19,659 22,828
Equipment and leasehold improvements, net 28,813 36,195
Equipment held for sale, net 400 2,281
Investment in and advances to unconsolidated entities, net 2,069 2,003
Intangible assets, net 1,269 831
Other assets 1,259 1,559
-------------------------
$53,469 $ 65,697
=========================
LIABILITIES AND NET CAPITAL DEFICIENCY:
Current liabilities:
Current portion long-term debt and capital lease obligations $11,541 $ 11,718
Current portion convertible subordinated debt 2,800 --
Accounts payable 2,062 2,544
Accrued payroll and related taxes 1,493 1,554
Other accrued liabilities 3,230 3,591
-------------------------
Total current liabilities 21,126 19,407
Long-term debt and capital lease obligations 25,406 35,509
Minority interest in consolidated partnerships 1,598 2,151
Convertible subordinated debt 8,200 11,000
Commitments
Net Capital Deficiency:
Preferred stock, no par value, 5,000,000 shares authorized;
Series B preferred shares, no par value, 300,000 shares
authorized, no shares issued or outstanding -- --
Common stock, no par value, 30,000,000 shares authorized;
12,133,227 and 11,805,425 shares issued and outstanding
at December 31, 1994 and 1993, respectively 54,473 53,670
Common shares issuable -- 800
Accumulated deficit (57,334) (56,840)
-------------------------
Total Net Capital Deficiency (2,861) (2,370)
-------------------------
$53,469 $ 65,697
=========================
</TABLE>
See accompanying notes.
F-2
<PAGE> 30
MEDICAL IMAGING CENTERS OF AMERICA, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
<TABLE>
<CAPTION>
Year Ended December 31,
--------------------------------
(in thousands except per share information) 1994 1993 1992
---------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
REVENUES:
Medical services $55,440 $ 65,786 $ 74,258
Equipment and medical suite sales 1,866 3,011 10,300
--------------------------------
Total revenues 57,306 68,797 84,558
COSTS AND EXPENSES:
Costs of medical services 33,693 42,786 50,476
Costs of equipment and medical suite sales 1,749 2,664 9,601
Marketing, general and administrative 5,550 7,872 11,802
Provision for doubtful accounts 1,343 2,643 2,851
Depreciation and amortization of equipment
and leasehold improvements 12,221 12,672 11,517
Amortization of intangibles and deferred costs 501 1,325 1,177
Equity in net income of unconsolidated entities (708) (531) (378)
Interest expense 5,123 6,324 7,777
Interest income (454) (657) (1,417)
Litigation settlement -- -- 1,020
Special charge -- 23,490 10,037
--------------------------------
Total costs and expenses 59,018 98,588 104,463
--------------------------------
Loss before minority interest, income taxes and extraordinary gain (1,712) (29,791) (19,905)
Minority interest in net (income) loss of
consolidated partnerships (98) 178 (377)
--------------------------------
Loss before income taxes and extraordinary gain (1,810) (29,613) (20,282)
Income tax provision -- -- 60
--------------------------------
Loss before extraordinary gain (1,810) (29,613) (20,342)
Extraordinary gain 1,316 -- --
--------------------------------
Net loss $ (494) $(29,613) $(20,342)
================================
NET LOSS PER COMMON SHARE:
Loss before extraordinary gain $ (.15) $ (2.51) $ (1.72)
Extraordinary gain $ 0.11 $ -- $ --
--------------------------------
Net loss $ (.04) $ (2.51) $ (1.72)
================================
Shares used in per share amounts 12,129 11,805 11,801
================================
</TABLE>
See accompanying notes.
F-3
<PAGE> 31
MEDICAL IMAGING CENTERS OF AMERICA, INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (NET CAPITAL DEFICIENCY)
<TABLE>
<CAPTION>
Common Shares
---------------------------------------------------
Issued and Outstanding Issuable Accumulated
---------------------- -------------------
(in thousands except share information) Shares Amount Shares Amount Deficit
--------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
Balance at December 31, 1991 11,774,725 $53,600 -- $ -- $ (6,885)
1992
Stock options exercised 30,700 70 -- -- --
Litigation settlement -
common shares issuable -- -- 324,470 800 --
Net loss -- -- -- -- (20,342)
-----------------------------------------------------------------
Balance at December 31, 1992 11,805,425 53,670 324,470 800 (27,227)
1993
Net loss -- -- -- -- (29,613)
-----------------------------------------------------------------
Balance at December 31, 1993 11,805,425 53,670 324,470 800 (56,840)
1994
Stock options exercised 3,332 3 -- -- --
Litigation settlement -
common shares issued 324,470 800 (324,470) (800) --
Net loss -- -- -- -- (494)
-----------------------------------------------------------------
Balance at December 31, 1994 12,133,227 $54,473 -- $ -- $(57,334)
=================================================================
</TABLE>
See accompanying notes
F-4
<PAGE> 32
MEDICAL IMAGING CENTERS OF AMERICA, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
Year Ended December 31,
-----------------------------------------
(in thousands) 1994 1993 1992
--------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
OPERATING ACTIVITIES:
Net loss $ (494) $(29,613) $(20,342)
Adjustments to reconcile net loss to net cash
provided by operating activities:
Depreciation and amortization 12,722 13,997 12,694
Provision for doubtful accounts 1,343 2,643 2,851
Litigation settlement charge -- -- 800
Special charge -- 23,490 10,037
Equity in net income of unconsolidated entities,
net of distributions (430) (260) (100)
Minority interest in net income (loss) of consolidated partnerships 98 (178) 377
Net value of equipment sold 1,404 4,700 4,762
Extraordinary gain (1,316) -- --
Change in assets and liabilities:
Decrease (increase) in trade receivables 1,937 (1,210) (1,051)
Decrease (increase) in prepaid expenses and other current assets 346 1,125 (1,101)
Decrease in accounts payable and other accrued liabilities (634) (2,180) (1,592)
Decrease in accrued payroll and related taxes (61) (913) (420)
Decrease in refundable income taxes and other -- 494 2,305
-----------------------------------------
Net cash provided by operating activities 14,915 12,095 9,220
INVESTING ACTIVITIES:
Proceeds from the sale of long-term investments -- 2,750 --
(Increase) decrease in refundable deposits on equipment (61) 215 116
Capital expenditures (3,004) (3,286) (12,287)
Decrease in notes receivable 200 114 745
Decrease in investment in and advances to
unconsolidated entities, net 368 197 179
Cost of acquisitions, net of cash acquired (657) -- --
Other, net 80 172 (684)
-----------------------------------------
Net cash (used in) provided by investing activities (3,074) 162 (11,931)
FINANCING ACTIVITIES:
Proceeds from the issuance of long-term debt 1,123 7,089 12,215
Principal payments on long-term debt and capital lease obligations (11,904) (15,510) (10,486)
Distribution to minority interests (590) (459) (1,042)
Other, net (128) (57) (442)
-----------------------------------------
Net cash (used in) provided by financing activities (11,499) (8,937) 245
-----------------------------------------
Net increase (decrease) in cash and cash equivalents 342 3,320 (2,466)
Cash and cash equivalents at beginning of year 8,182 4,862 7,328
-----------------------------------------
Cash and cash equivalents at end of period $ 8,524 $ 8,182 $ 4,862
=========================================
</TABLE>
See accompanying notes
F-5
<PAGE> 33
MEDICAL IMAGING CENTERS OF AMERICA, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
<TABLE>
<CAPTION>
Year Ended December 31,
---------------------------------------
(in thousands) 1994 1993 1992
-----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
SUPPLEMENTAL CASH FLOW DATA:
Interest paid $5,123 $5,918 $7,600
=======================================
Income taxes paid $ 67 $ 88 $ 70
=======================================
SUPPLEMENTAL NON-CASH INVESTING
AND FINANCING ACTIVITIES:
Additions to capital lease obligations $8,545 $7,481 $2,598
=======================================
Retirement of debt and termination of capital lease
obligations in exchange for equipment $7,075 $7,655 $ --
=======================================
Acquisitions:
Fair value of assets acquired, other than cash $ 266 $ -- $ --
Excess of purchase price over fair value 875 -- --
Cost of acquisitions, net of cash acquired (484) -- --
---------------------------------------
$ 657 $ -- $ --
=======================================
Equipment sold under sales-type leases and
direct financing leases $ -- $ -- $ 32
=======================================
Conversion of notes and other receivables to
investment in unconsolidated entities $ -- $ -- $ 577
=======================================
Common shares issuable for litigation settlement $ -- $ -- $ 800
=======================================
</TABLE>
See accompanying notes.
F-6
<PAGE> 34
MEDICAL IMAGING CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
PRINCIPLES OF CONSOLIDATION - The accompanying financial statements
consolidate the accounts of the Company, its wholly-owned subsidiaries, and
certain majority controlled Diagnostic Medical Centers ("DMC's"). Investments in
DMC's for which the Company does not have a controlling majority ownership are
accounted for using the equity method. All significant intercompany accounts and
transactions have been eliminated in consolidation.
REVENUES - Revenue is recognized when services are provided through
DMC's, fee-for-service arrangements with hospitals and management agreements
with unconsolidated and managed DMC's.
CASH AND CASH EQUIVALENTS - The Company considers cash equivalents to
be those instruments with original maturities of three months or less. At
December 31, 1994 and 1993, cash restricted for use in DMC operations is
$832,000 and $853,000, respectively.
NET LOSS PER SHARE - Net loss per common share is computed on the basis
of the weighted average number of common shares. The effect of outstanding stock
options, warrants and convertible debentures was antidilutive in the years ended
1994, 1993 and 1992 and is therefore excluded from the computation of net loss
per common share.
RECLASSIFICATIONS - Certain amounts in the 1993 and 1992 financial
statements have been reclassified to conform with the 1994 presentation.
Other - See Notes 5, 6 and 10 for accounting policies related to
depreciation, amortization and income taxes.
2. LIQUIDITY
The accompanying financial statements have been prepared assuming that
the Company will continue as a going concern. Although the Company has a working
capital deficit of $1.5 million, management believes that its cash on hand of
$8.5 million is adequate to ensure the timely payment of its scheduled mandatory
redemption of convertible debentures of $2.8 million and to fund its ongoing
operations through 1995. Management is negotiating to restructure its
convertible debenture debt on terms more favorable to the Company. There can be
no assurances, however, that cash generated from operations will be sufficient
to sustain the operations of the Company through 1995 or that management will be
successful in its efforts to restructure its convertible debenture debt.
F-7
<PAGE> 35
3. RECEIVABLES
The following is a summary of receivables:
<TABLE>
<CAPTION>
December 31,
-----------------------
(in thousands) 1994 1993
-------------------------------------------------------------------------------
<S> <C> <C>
Trade accounts receivable less allowance of
$5,554 in 1994 and $6,195 in 1993 $ 10,244 $ 13,200
Notes receivable, less allowance of $492 in 1994
and $688 in 1993 40 464
-----------------------
10,284 13,664
Less current trade and notes receivable (9,524) (12,749)
-----------------------
Long-term receivables $ 760 $ 915
=======================
</TABLE>
Long-term receivables, which include DMC trade receivables which are
not expected to be collected within one year, are included in Other assets on
the accompanying consolidated balance sheets. The Company's trade receivables
are primarily from hospitals and third party payor groups operating throughout
the United States.
F-8
<PAGE> 36
4. INVESTMENT IN AND ADVANCES TO UNCONSOLIDATED ENTITIES
The Company has investments in certain DMC's which are accounted for
using the equity method. Unaudited summarized combined financial information for
the unconsolidated DMC's is as follows:
BALANCE SHEETS
<TABLE>
<CAPTION>
December 31,
---------------------
(in thousands) 1994 1993
--------------------------------------------------------------------------------
<S> <C> <C>
Current assets $ 5,288 $4,418
Equipment and leasehold improvements, net 5,432 2,861
Other assets 126 204
---------------------
$10,846 $7,483
=====================
Current liabilities $ 2,388 $1,736
Advances from MICA 2,285 2,620
Long-term debt and capital lease obligations 4,020 2,385
Partners' equity 2,153 742
---------------------
$10,846 $7,483
=====================
</TABLE>
The Company's share of partners' equity in unconsolidated DMC's is
$1,393,000 and $678,000 at December 31, 1994 and 1993, respectively. The Company
has recorded valuation allowances at December 31, 1994 and 1993 of $1,788,000
and $1,688,000, respectively and advances to unconsolidated entities of
$2,464,000 and $2,808,000, respectively.
STATEMENTS OF OPERATIONS
<TABLE>
<CAPTION>
Year Ended December 31,
---------------------------------------
(in thousands) 1994 1993 1992
--------------------------------------------------------------------------------
<S> <C> <C> <C>
Revenues $11,279 $10,986 $12,626
Costs and expenses 8,587 8,657 10,997
---------------------------------------
Net income $ 2,692 $ 2,329 $ 1,629
=======================================
</TABLE>
The Company's revenues include $744,000, $737,000 and $911,000 for the
years ended 1994, 1993 and 1992 respectively from management fees from the
unconsolidated DMC's.
The Company has guaranteed $5,699,000 in capital lease and debt
obligations of its unconsolidated DMC's with terms through 2000.
F-9
<PAGE> 37
5. EQUIPMENT AND LEASEHOLD IMPROVEMENTS
Equipment and leasehold improvements are carried at the lower of cost
or net realizable value and are summarized as follows:
<TABLE>
<CAPTION>
December 31,
-----------------------
(in thousands) 1994 1993
-------------------------------------------------------------------------------
<S> <C> <C>
Equipment and furniture, net of valuation reserve
of $7,026 in 1994 and $5,572 in 1993 $ 59,280 $ 61,072
Leasehold improvements 3,207 3,212
-----------------------
62,487 64,284
Accumulated depreciation and amortization (33,674) (28,089)
-----------------------
$ 28,813 $ 36,195
=======================
</TABLE>
Depreciation and amortization are calculated on a straight-line basis
over the estimated useful life of the asset or over the lease term, if shorter.
Lease terms are generally five to seven years for equipment and furniture and
fifteen years for leasehold improvements. Equipment includes assets financed
through capital leases of $27,965,000 and $29,965,000 with accumulated
amortization of $10,825,000 and $10,297,000 at December 31, 1994 and 1993,
respectively.
Management intends to sell certain equipment used during the year in
the Company's on-going business operations. Accordingly, this equipment has been
classified as equipment held for sale at its estimated realizable value at
December 31, 1994 and 1993.
6. INTANGIBLE ASSETS
Intangible assets consist of the following:
<TABLE>
<CAPTION>
December 31,
-----------------
(in thousands) 1994 1993
--------------------------------------------------------------------------------
<S> <C> <C>
Excess of purchase price over net assets acquired,
less accumulated amortization of $142 in 1994 $ 742 $ --
Deferred costs, less accumulated amortization
of $1,464 in 1994 and $1,187 in 1993 527 831
-----------------
$1,269 $831
=================
</TABLE>
During 1994, the Company acquired certain assets of two imaging centers
and additional limited partner units in certain of its DMC's for a total of
$657,000 cash and $484,000 promissory notes. Of the total purchase price,
$875,000 was allocated to goodwill and is being amortized using the
straight-line method over the estimated useful life of the assets which is three
years. The Company's results of operations were not materially affected as a
result of these acquisitions.
The Company periodically reviews goodwill to assess recoverability
based upon projected cash flows to be received from operating income. If such
cash flows are less than the carrying value of goodwill the difference will be
charged to expense.
Deferred costs primarily include debt financing costs incurred in
connection with the issuance of debentures which have been deferred and are
being amortized on a weighted average basis over the term of the indebtedness.
F-10
<PAGE> 38
7. DEBT
Long-term debt for equipment financing consists of the following:
<TABLE>
<CAPTION>
December 31,
-----------------------
(in thousands) 1994 1993
-------------------------------------------------------------------------------------------------
<S> <C> <C>
Note payable to a bank - effective interest rate of 10.5%;
amortization of $50,000 per month;
final payment due December 31, 1995 $ 600 $ 1,350
Equipment installment loans payable - weighted average interest rate
of approximately 10%; due at various dates through 2000 17,767 23,465
Capital lease obligations - weighted average interest rate
of approximately 12%; due at various dates through 1999 18,580 22,412
-----------------------
36,947 47,227
Less current maturities (11,541) (11,718)
-----------------------
$ 25,406 $ 35,509
=======================
</TABLE>
Maturities on notes payable and long-term debt over the next five years
are as follows:
<TABLE>
<CAPTION>
(in thousands)
Years Ending December 31,
--------------------------------------------------------------------------------
<S> <C>
1995 $ 6,750
1996 5,494
1997 4,203
1998 1,227
1999 469
Thereafter 224
-------
$18,367
=======
</TABLE>
The Company finances certain equipment under capital leases. These
capital leases generally have terms of five to seven years. Future minimum
payments under capital leases are as follows:
<TABLE>
<CAPTION>
(in thousands)
Years Ending December 31,
-------------------------------------------------------------------------------
<S> <C>
1995 $ 6,315
1996 5,878
1997 5,288
1998 2,855
1999 1,721
Thereafter --
--------
Total minimum lease payments 22,057
Amounts representing interest (3,477)
--------
Present value of future minimum lease payments 18,580
Less amounts due in one year (4,791)
--------
Long-term capital lease obligations $ 13,789
========
</TABLE>
F-11
<PAGE> 39
8. CONVERTIBLE SUBORDINATED DEBT
Convertible subordinated debentures are due in 1999 with interest
payable semi-annually. The debentures are convertible into MICA Common Stock at
$3 per share and may be redeemed by the Company if the closing bid price of the
Company's Common Stock on any 20 consecutive trading days has been at least
$4.50 per share. The Company is required to redeem the debentures on April 30 as
follows: 1995 - $2,800,000; 1996 - $2,800,000; and 1997 - $2,600,000. The final
payment of $2,800,000 is due April 30, 1999. The debenture agreement related to
this financing contains restrictions on the payment of cash dividends based upon
an accumulative net income test with certain adjustments. The debenture
agreement also has limitations on the reacquisition of shares and requires a
Minimum Consolidated Shareholders' Equity. In addition, the holders of the
debentures may require prepayment in excess of the unpaid principal amount, in
the event of a change in control of the Company.
In April of 1993, the convertible subordinated debenture holders agreed
to a permanent reduction in the interest rate from 12% to 6% on this debt. In
February of 1994, the convertible subordinated debenture holders agreed to
exclude the 1993 non-cash charge of approximately $21,500,000 related to
goodwill from the definition of Minimum Shareholders' Equity. In return, the
Company agreed to an increase in the Minimum Shareholders' Equity covenant from
$5,190,000 to $10,000,000. At December 31, 1994, the Company is in compliance
with all debt covenants.
9. COMMITMENTS
The Company leases its facilities and certain equipment under operating
lease agreements with terms ranging from three to twenty years. Certain facility
lease agreements provide for rent increases based on the increases in the
Consumer Price Index and operating costs. Also, the Company has the option to
renew certain facility leases for additional terms varying from five to ten
years.
The Company's consolidated DMC's have entered into multi-year equipment
maintenance agreements. Future minimum payments under operating leases and
equipment maintenance agreements are as follows:
<TABLE>
<CAPTION>
(in thousands)
Years Ending December 31,
--------------------------------------------------------------------------------
<S> <C>
1995 $ 6,676
1996 3,794
1997 2,382
1998 1,631
1999 677
Later years 827
-------
Total minimum payments $15,987
=======
</TABLE>
Rent expense under operating leases totalled $8,263,000, $11,509,000,
and $16,175,000 for the years ended December 31, 1994, 1993 and 1992,
respectively, and is included in Costs of medical services in the Company's
consolidated statements of operations.
10. INCOME TAXES
The Company accounts for income taxes using FAS Statement No. 109,
Accounting for Income Taxes. Statement 109 is an asset and liability approach
that requires the recognition of deferred tax assets and liabilities for the
expected future tax consequences of events that have been recognized in the
Company's financial statements or tax returns. In estimating future tax
consequences, Statement 109 generally considers all expected future events other
than enactments of changes in the tax law or rates.
F-12
<PAGE> 40
At December 31, 1994, the Company had Federal net operating loss
carryforwards of approximately $30,900,000 for income tax purposes that expire
in 2008. The Company has investment tax credit carryforwards of approximately
$418,000 which begin to expire in 1999. In addition, the Company has an
alternative minimum tax credit carryforward of approximately $282,000. In
accordance with the Internal Revenue Code, the Company's use of its net
operating loss carryforwards could be limited in the event of certain cumulative
changes in the Company's stock ownership. For financial reporting purposes, a
valuation allowance of approximately $14,156,000 has been recognized to offset
the deferred tax assets.
Deferred income taxes reflect the net tax effects of temporary
differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant
components of the Company's deferred tax liabilities and assets are as follows:
<TABLE>
<CAPTION>
December 31,
-----------------------
(in thousands) 1994 1993
-------------------------------------------------------------------------------
<S> <C> <C>
Deferred tax assets:
Net operating loss carryforwards $ 10,655 $ 13,521
Valuation reserves 5,160 5,868
Other 4,308 4,169
-----------------------
Total deferred tax assets 20,123 23,558
Valuation allowance for deferred tax assets (14,156) (16,224)
-----------------------
Net deferred tax assets 5,967 7,334
-----------------------
Deferred tax liabilities:
Tax over financial reporting depreciation 5,967 7,334
-----------------------
Total deferred tax liabilities 5,967 7,334
-----------------------
Net deferred tax liabilities $ -- $ --
=======================
</TABLE>
The reconciliation of income tax computed at the U.S. federal statutory
tax rates to the income tax provision is as follows:
<TABLE>
<CAPTION>
Year Ended December 31, 1994 1993 1992
-------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Statutory provision (34.0%) (34.0%) (34.0%)
Limitation of benefit on net operating loss 32.3 16.6 32.6
Non-deductible amortization expense -- 17.4 --
Other 1.7 -- 1.7
----------------------------
--% --% .3%
============================
</TABLE>
For the year ended 1992, MICA had a current state tax provision of
$60,000. No tax provisions have been recorded for the years ended 1993 and 1994.
11. SHAREHOLDERS' EQUITY
Common Stock - At December 31, 1994, the Company had reserved 7,886,667
shares of Common Stock for issuance in connection with the exercise of
outstanding stock options and warrants and the conversion of debentures.
F-13
<PAGE> 41
In March 1993, the court approved the settlement of the class action
lawsuit brought in 1991 against the Company and certain former officers. The
settlement provided for the Company to issue 324,470 shares of its Common Stock
at an agreed upon value of $800,000 and for the insurers of the individual
defendants to pay $2,650,000. On January 3, 1994, the Company issued 324,470
shares related to the litigation settlement.
PREFERRED STOCK-SERIES B - In October 1991, the Company's Board of
Directors authorized 300,000 shares of Series B Preferred Stock without par
value. Each share of Series B Preferred Stock shall entitle the holder thereof
to 100 votes on all matters submitted to a vote of the shareholders. Dividends
shall begin to accrue and be cumulative on outstanding shares in an amount equal
to the greater of one dollar ($1.00) per share or 100 times the aggregate per
share amount of any cash or non-cash dividends declared on the Common Stock.
WARRANTS - The Company issues warrants primarily to directors,
underwriters and consultants for various services. Warrants are generally
granted at prices equal to the fair market value of the shares on the date of
grant. At year end 277,500 warrants were exercisable. Warrant activity during
1994 and 1993 is summarized as follows:
<TABLE>
<CAPTION>
Number Price
of Shares Per Share
--------------------------------------------------------------------------------
<S> <C> <C>
Outstanding at December 31, 1991 246,000 $8.40 - $13.63
Granted 310,000 2.75 - 4.38
Forfeited (165,000) 8.40 - 12.63
--------------------------------
Outstanding at December 31, 1992 391,000 2.75 - 13.63
Granted 2,437,500 .50 - 1.14
Forfeited (81,000) 9.75 - 13.63
--------------------------------
Outstanding at December 31, 1993 2,747,500 .50 - 4.38
Granted 35,000 .56 - .56
Forfeited (205,000) 2.75 - 4.38
--------------------------------
Outstanding at December 31, 1994 2,577,500 $ .50 - $3.75
================================
</TABLE>
PREFERRED STOCK PURCHASE RIGHTS
In October 1991, the Company's Board of Directors declared a dividend
distribution of one preferred share purchase right (a "Right") for each share of
Company Common Stock ("Common Share") outstanding at the close of business on
October 18, 1991 (the "Record Date"). Each Right entitles the registered holder
to purchase from the Company one one-hundredth of a share of Series B Preferred
Stock, no par value, at a purchase price of thirty-five dollars ($35.00) per one
one-hundredth of a Preferred Share, subject to adjustment. The Board of
Directors has also authorized and directed the issuance of one Right with
respect to each Common Share that shall become outstanding between the Record
Date and the earliest of the Distribution Date (as defined below), the date the
Rights are redeemed and the date the Rights expire.
The Rights will separate from the Common Shares and a Distribution Date
will occur upon the earlier of (i) the tenth day following a public announcement
that a person or group of affiliated or associated persons has acquired, or
obtained the right to acquire, beneficial ownership of 20% or more of the
outstanding Common Shares or (ii) the tenth day following the commencement of or
announcement of an intention to make a tender offer or exchange offer, the
consummation of which would result in a person or group beneficially owning 30%
or more of such outstanding Common Shares.
The Rights are not exercisable until the Distribution Date and will
expire at the close of business on October 2, 2001, unless extended. At any time
prior to or within 10 days after the Distribution Date, the Board of Directors
may redeem the Rights in whole, but not in part, at a price of $.01 per Right.
Until a Right is exercised, the holder thereof, as such, will have no rights as
a shareholder of the Company, including, without limitation, the right to vote
or to receive dividends.
F-14
<PAGE> 42
12. RETIREMENT PLAN AND STOCK OPTIONS
RETIREMENT PLAN - Under Section 401(k) of the Internal Revenue Code the
Company instituted a tax deferred retirement plan (the "TDRP") for the benefit
of all employees meeting certain minimum eligibility requirements. Under the
TDRP, an employee may defer up to 10% of pre-tax earnings, subject to certain
limitations, and contribute it to a trusteed plan. The Company will match 50% of
an employee's deferred salary up to a maximum of 4% of gross pay. The Company's
matching contributions vest over a seven-year period. For the years ended
December 31, 1994, 1993 and 1992, the Company contributed $101,000, $135,000,
and $94,000, respectively, to match employee contributions.
STOCK OPTIONS - The Company has been authorized to issue 2,445,000
shares of Common Stock to certain key employees under Stock Option Plans adopted
in 1983, 1984, 1985 and 1994. Options are granted at prices equal to the fair
market value of the shares at the date of grant and are usually exercisable in
cumulative annual increments each year, commencing one year after the date of
grant. Activity under the Company's stock option plans during 1994 and 1993 are
summarized as follows:
<TABLE>
<CAPTION>
Number Price
of Shares Per Share
--------------------------------------------------------------------------------
<S> <C> <C>
Outstanding at December 31, 1991 722,900 $2.25 - $11.13
Granted 727,500 3.75 - 4.38
Exercised (30,700) 2.25 - 2.75
Forfeited (730,367) 2.25 - 11.13
-----------------------------
Outstanding at December 31, 1992 689,333 2.75 - 4.38
Granted 614,000 .63 - .88
Forfeited (529,833) .63 - 4.38
-----------------------------
Outstanding at December 31, 1993 773,500 .63 - 4.38
Granted 804,000 .47 - .72
Exercised (3,332) .63
Forfeited (490,668) .47 - 4.38
-----------------------------
Outstanding at December 31, 1994 1,083,500 $ .47 - $ 4.38
=============================
</TABLE>
Options exercisable at December 31, 1994 totalled 479,001 and shares
available for future grant at year end totalled 790,927.
13. SPECIAL CHARGES
Operating results in 1993 include a non-cash charge of approximately
$21,500,000 to write off goodwill associated with prior years' acquisitions and
a non-cash charge of $2,000,000 to increase reserves established to reflect
uncertainty regarding the realization of certain other assets.
Operating results in 1992 include a special charge of $10,037,000 to
establish reserves for uncertainty regarding the collectability of payments for
assets sold under sales-type lease arrangements in 1991 and to adjust certain
assets and accounts receivable to net realizable value. The cash portion of the
1992 special charge represents
F-15
<PAGE> 43
10% of the total charge and relates to relocation and severance costs associated
with the closing of its division office in Illinois. Operating results in 1991
included a special charge of $5,592,000 to establish reserves for costs incurred
in the phase-out of the medical suite business and to adjust certain assets and
purchase commitments to net realizable value. The cash portion of the 1991
special charge represents 10% of the total charge and relates to costs
associated with the phaseout of certain division offices.
14. EXTRAORDINARY GAIN
The Company financed an equipment acquisition for one of its managed
DMCs. The operations of the DMC were unsuccessful and foreclosure proceedings
were initiated by the lender. In mitigation of damages, the underlying lender
arranged for the sale of the unit which resulted in the forgiveness of MICA's
indebtedness. In 1994, the Company recorded a non-cash extraordinary gain of
$1.3 million resulting from the forgiveness of debt related to certain MRI
equipment.
15. RELATED PARTY TRANSACTIONS
During the years ended December 31, 1994, 1993 and 1992, the Company
reported net revenues of $6,642,000, $6,091,000 and $5,576,000, respectively,
which were generated from an entity in which one of the Company's directors has
an ownership interest.
<PAGE> 44
MEDICAL IMAGING CENTERS OF AMERICA, INC.
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
----- ADDITIONS -----
<TABLE>
<CAPTION>
BALANCE AT CHARGED TO CHARGED TO BALANCE AT
BEGINNING COSTS AND OTHER END
(in thousands) OF PERIOD EXPENSES ACOUNTS DEDUCTIONS OF PERIOD
----------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
YEAR ENDED 12/31/94:
Reserve for bad debts $6,883 $1,243 $--- $2,080 $6,046
====== ====== ======= ====== ======
Reserve for advances to
unconsolidated centers $1,688 $100(1) $--- $--- $1,788
====== ====== ======= ====== ======
Amortization of intangibles:
Excess of purchase price over
net assets acquired $0 $142 $--- $--- $142
====== ====== ======= ====== ======
Amortization of deferred costs:
Debt financing costs $723 $135 $--- $--- $858
Pre-opening and
organization costs 267 192 --- 77 382
Indirect lease origination
costs 197 32 --- 5 224
------ ------ ------- ------ ------
Total $1,187 $359 $0 $82 $1,464
====== ====== ======= ====== ======
======================================================================================================================
YEAR ENDED 12/31/93:
Reserve for bad debts $5,465 $2,643 $0 $1,225 $6,883
====== ====== ======= ====== ======
Reserve for contract costs in
excess of related revenues $735 $--- $--- $735(2) $0
====== ====== ======= ====== ======
Reserve for advances to
unconsolidated centers $900 $--- $788 (3) --- $1,688
====== ====== ======= ====== ======
Amortization of intangibles:
Excess of purchase price over
net assets acquired $1,756 $521 ($2,267)(4) $10 $0
Covenants not to compete, contracts
acquired and rights to provide
MRI equipment 574 246 (820)(4) --- 0
------ ------ ------- ------ ------
Total $2,330 $767 ($3,087) $10 $0
====== ====== ======= ====== ======
Amortization of deferred costs:
Debt financing costs $588 $135 $--- $--- $723
Pre-opening and
organization costs 203 266 --- 202 267
Indirect lease origination
costs 228 157 --- 188 197
------ ------ ------- ------ ------
Total $1,019 $558 $0 $390 $1,187
====== ====== ======= ====== ======
======================================================================================================================
</TABLE>
(1) Represents increase in reserve for advances to unconsolidated centers (KC).
(2) Represents reserves written off due to contracts expiring during 1993.
(3) Represents reclass of general reserve to reserve for advances to
unconsolidated centers.
(4) Represents write off of goodwill.
<PAGE> 45
MEDICAL IMAGING CENTERS OF AMERICA, INC.
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
----- ADDITIONS -----
<TABLE>
<CAPTION>
BALANCE AT CHARGED TO CHARGED TO BALANCE AT
BEGINNING COSTS AND OTHER END
(in thousands) OF PERIOD EXPENSES ACOUNTS DEDUCTIONS OF PERIOD
----------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
YEAR ENDED 12/31/92:
Reserve for bad debts $3,408 $2,682 $254(1) $879(2) $5,465
====== ====== ======= ====== ======
Reserve for contract costs in
excess of related revenues $900 $500(3) $--- $665(4) $735
====== ====== ======= ====== ======
Reserve for advances to
unconsolidated centers $731 $169 $--- --- $900
====== ====== ======= ====== ======
Amortization of intangibles:
Excess of purchase price over
net assets acquired $1,261 $495 $--- $0 $1,756
Covenants not to compete, contracts
acquired and rights to provide
MRI equipment 328 246 --- --- 574
------ ------ ------- ------ ------
Total $1,589 $741 $0 $0 $2,330
====== ====== ======= ====== ======
Amortization of deferred costs:
Debt financing costs $453 $135 $0 $--- $588
Pre-opening and
organization costs 99 104 --- --- 203
Indirect lease origination
costs 400 197 --- 369 228
------ ------ ------- ------ ------
Total $952 $436 $0 $369 $1,019
====== ====== ======= ====== ======
======================================================================================================================
</TABLE>
(1) - Represents reserve for bad debt "acquired" in conjunction with the
acquisition of additional Limited Partnership interest in the Orlando
Diagnostic Center.
(2) - Represents write-off of uncollectible accounts receivable.
(3) - Represents reserve for certain fee-for-service agreements where
anticipated future costs exceed anticipated future revenues.
(4) - Represents reserves written off due to contracts expiring during 1992.
<PAGE> 1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statement
(Form S-8, No. 33-29917) pertaining to the 1983 Employee Stock Option Plan, the
1984 Employee Stock Option Plan and the 1985 Employee Stock Option Plan of
Medical Imaging Centers of America, Inc. and in the related Prospectus of our
report dated February 17, 1995, with respect to the consolidated financial
statements of Medical Imaging Centers of America, Inc. included in its Annual
Report (Form 10-K\A) for the year ended December 31, 1994.
ERNST & YOUNG LLP
San Diego, California
August 31, 1995
